Open AccessHuman papilloma virus genotype distribution and risk factor analysis amongst reproductive-age women in urban Gambia
Author(s) -
H. Bah Camara,
Mathew Anyanwu,
Edward Wright,
P.T. Kimmitt
Publication year - 2018
Publication title -
journal of medical microbiology/journal of medical microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.91
H-Index - 117
eISSN - 1473-5644
pISSN - 0022-2615
DOI - 10.1099/jmm.0.000848
Subject(s) - genotype , cervical cancer , genotyping , hpv infection , ureaplasma urealyticum , medicine , gynecology , risk factor , sex organ , cancer , biology , gene , genetics , mycoplasma
Cervical cancer is the most frequently diagnosed female cancer in The Gambia, representing approximately 30 % of cases. In 2014, the quadrivalent human papilloma virus (HPV) vaccine was introduced, which offers protection against HPV genotypes 6, 11, 16 and 18. To evaluate the potential effectiveness of this vaccine, genotype distribution and risk factor analysis were assessed.